Insider buying
~$108K8,138 sh @ $13.26
Traded Nov 13 · filed 3 days later
Since the trade −18.4% · S&P 500 −8.6% · to Nov 20
Bought 36% below the 52-week high, RSI 31, 15% under its 200-day average
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 2 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider buying
Traded Nov 13 · filed 3 days later
Since the trade −18.4% · S&P 500 −8.6% · to Nov 20
Bought 36% below the 52-week high, RSI 31, 15% under its 200-day average
A major shareholder of Pedevco paid $108K out of pocket for Pedevco shares. 1 other person at Pedevco bought some too, in the same month.
Lately at Pedevco: the stock fell 12% in one session on Nov 17 with press coverage; it reported its results on Nov 13; the stock is down 35% in 30 days.
Insider selling
Traded Nov 16 · filed the same day
A Royalty Pharma officer told the SEC about a plan to sell $17.6M of Royalty Pharma shares around Nov 16, 2026. The shares were not acquired as compensation. That is a tiny part of all Royalty Pharma shares.
Lately at Royalty Pharma: it reported its results on Nov 4; the stock is up 10% in 30 days.
Insider buying
Traded Nov 16 · filed the same day
Since the trade −12.8% · S&P 500 −6.8% · to Nov 20
The CFO of Hawkeye 360 paid $10K out of pocket for Hawkeye 360 shares. 7 other people at Hawkeye 360 bought some too, in the same month.
Lately at Hawkeye 360: the stock rose 24% in one session on Nov 13 around a company release; it reported its results on Nov 12; the stock is up 36% in 30 days.
Insider buying
First insider buy since Sep 2025Traded Nov 12 · filed 4 days later
Since the trade −6.7% · S&P 500 −8.9% · to Nov 20
Bought within 3% of the 52-week high, RSI 55, 12% above its 200-day average
An Orrstown Financial Services director paid $11K out of pocket for Orrstown Financial Services shares. 1 other person at Orrstown Financial Services bought some too, in the same month. It was the first purchase in 25 months.
Lately at Orrstown Financial Services: it reported its results on Oct 21.
Insider buying
First insider buy since Mar 2025Traded Nov 16 · filed the same day
Since the trade −3.9% · S&P 500 −6.8% · to Nov 20
Bought within 5% of the 52-week low, RSI 30, 29% under its 200-day average, 26 points behind the S&P 500 over 3 months
A Tredegar director paid $97K out of pocket for Tredegar shares. Shares held went up 12% with this purchase.
Lately at Tredegar: the stock fell 23% in one session on Nov 6 around a company release; it reported its results on Nov 6; the stock is down 32% in 30 days.
Insider buying
First insider buy since Aug 2025Traded Nov 12 · filed 4 days later
Since the trade −8.2% · S&P 500 −8.9% · to Nov 20
Bought 33% below the 52-week high, RSI 57, 12% under its 200-day average
Sunrise Realty Trust's President paid $34K out of pocket for Sunrise Realty Trust shares. 1 other person at Sunrise Realty Trust bought some too, in the same month. It was the first purchase in over a year.
Lately at Sunrise Realty Trust: it reported its results on Nov 10; the stock is 38% below its 12-month high; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 16 · filed the same day
Since the trade −5.5% · S&P 500 −6.8% · to Nov 20
Bought 15% below the 52-week high, RSI 40, 4% under its 200-day average
A Third Coast Bancshares director paid $25K out of pocket for Third Coast Bancshares shares. 1 other person at Third Coast Bancshares bought some too, in the same month. It was the first purchase in 19 months.
Lately at Third Coast Bancshares: it reported its results on Oct 21; the stock is down 9% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 13 · filed 3 days later
Since the trade −10.2% · S&P 500 −8.6% · to Nov 20
Bought 34% below the 52-week high, RSI 28, 26% above its 200-day average
The CEO of Atlassian paid $107K out of pocket for Atlassian shares.
Lately at Atlassian: the stock fell 16% in one session on Nov 6 around a company release; it changed a top executive or board member on Nov 5; the stock is down 40% in 30 days.
Traded Nov 13 – Nov 16, 2026 · largest single transaction ~$15K
Lately at Solaris Energy Infrastructure, Inc.: it reported its results on Nov 4; the stock is down 21% in 30 days; insiders made 11 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Nov 13, 2026~$15K · 230 sh @ $65.17
DetailsOfficial recordNov 16, 2026~$10K · 170 sh @ $60.00
DetailsOfficial recordTraded Nov 16, 2026 · largest single transaction ~$19.5MNot reported under a pre-arranged trading plan
Lately at Capri Holdings: the stock rose 16% in one session on Oct 30 around a company release; it changed a top executive or board member on Nov 12; the stock is up 12% in 30 days.
Nov 16, 2026~$19.5M · 1M sh @ $19.47
DetailsOfficial recordNov 16, 2026~$19.3M · 992K sh @ $19.47
DetailsOfficial recordNov 16, 2026~$8.15M · 393K sh @ $20.74
DetailsOfficial recordInsider buying
First insider buy since Nov 2023Traded Nov 13 · filed 3 days later
Since the trade −16.3% · S&P 500 −8.6% · to Nov 20
Bought within 3% of the 52-week low, RSI 25, 35% under its 200-day average, 31 points behind the S&P 500 over 3 months
A Corteva director paid $93K out of pocket for Corteva shares. 1 other person at Corteva bought some too, in the same month.
Lately at Corteva: the stock fell 24% in one session on Nov 12 around a company release; it reported its results on Nov 12; the stock is down 38% in 30 days.
Insider selling
Traded Nov 16 · filed the same day
A Royalty Pharma officer told the SEC about a plan to sell $10.3M of Royalty Pharma shares around Nov 16, 2026. The shares were not acquired as compensation. That is a tiny part of all Royalty Pharma shares.
Lately at Royalty Pharma: it reported its results on Nov 4; the stock is up 10% in 30 days.
Insider buying
Traded Nov 12 · filed 4 days later
Since the trade −16.4% · S&P 500 −8.9% · to Nov 20
Bought 57% below the 52-week high, RSI 31, 32% under its 200-day average, 44 points behind the S&P 500 over 3 months
An Electrocore director paid $54K out of pocket for Electrocore shares. 1 other person at Electrocore bought some too, in the same month.
Lately at Electrocore: the stock fell 31% in one session on Nov 12 with press coverage; it reported its results on Nov 4; the stock is down 40% in 30 days.
Insider buying
Traded Nov 12 · filed 4 days later
Since the trade −7.3% · S&P 500 −8.9% · to Nov 20
Bought 44% below the 52-week high, RSI 27, 23% under its 200-day average
An Adecoagro director paid $24K out of pocket for Adecoagro shares. Shares held went up 34% with this purchase.
Lately at Adecoagro: the stock is down 17% in 30 days.
Insider buying
Traded Nov 16 · filed the same day
Since the trade −6.5% · S&P 500 −6.8% · to Nov 20
Bought 48% below the 52-week high, RSI 29, 2% under its 200-day average
The CEO of Netsol Technologies paid $22K out of pocket for Netsol Technologies shares. 1 other person at Netsol Technologies bought some too, in the same month. It was the first purchase in 6 months.
Lately at Netsol Technologies: the stock fell 23% in one session on Nov 12 with press coverage; it reported its results on Nov 13; the stock is down 41% in 30 days.
Insider selling
Traded Nov 16 · filed the same day
A major shareholder of Levi Strauss told the SEC about a plan to sell $9.61M of Levi Strauss shares around Nov 16, 2026. The shares were not acquired as compensation. That is 0.4% of all Levi Strauss shares.
Lately at Levi Strauss &: the stock is up 9% in 30 days.
Insider buying
Traded Nov 13 · filed 3 days later
Since the trade −0.5% · S&P 500 −8.6% · to Nov 20
Bought 9% below the 52-week high, RSI 57, 5% above its 200-day average
A major shareholder of Donegal paid $143K out of pocket for Donegal shares.
Lately at Donegal Group: it reported its results on Oct 29; insiders made 14 purchases ($10K+) and 1 large sale ($250K+, not pre-arranged) in 90 days.